Correlation Between Lotus Pharmaceutical and Handa Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Lotus Pharmaceutical and Handa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lotus Pharmaceutical and Handa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lotus Pharmaceutical Co and Handa Pharmaceuticals, you can compare the effects of market volatilities on Lotus Pharmaceutical and Handa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lotus Pharmaceutical with a short position of Handa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lotus Pharmaceutical and Handa Pharmaceuticals.

Diversification Opportunities for Lotus Pharmaceutical and Handa Pharmaceuticals

-0.43
  Correlation Coefficient

Very good diversification

The 3 months correlation between Lotus and Handa is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Lotus Pharmaceutical Co and Handa Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Handa Pharmaceuticals and Lotus Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lotus Pharmaceutical Co are associated (or correlated) with Handa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Handa Pharmaceuticals has no effect on the direction of Lotus Pharmaceutical i.e., Lotus Pharmaceutical and Handa Pharmaceuticals go up and down completely randomly.

Pair Corralation between Lotus Pharmaceutical and Handa Pharmaceuticals

Assuming the 90 days trading horizon Lotus Pharmaceutical Co is expected to under-perform the Handa Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Lotus Pharmaceutical Co is 2.93 times less risky than Handa Pharmaceuticals. The stock trades about -0.04 of its potential returns per unit of risk. The Handa Pharmaceuticals is currently generating about 0.3 of returns per unit of risk over similar time horizon. If you would invest  5,190  in Handa Pharmaceuticals on September 29, 2024 and sell it today you would earn a total of  2,180  from holding Handa Pharmaceuticals or generate 42.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Lotus Pharmaceutical Co  vs.  Handa Pharmaceuticals

 Performance 
       Timeline  
Lotus Pharmaceutical 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Lotus Pharmaceutical Co are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Lotus Pharmaceutical is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Handa Pharmaceuticals 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Handa Pharmaceuticals are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Handa Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Lotus Pharmaceutical and Handa Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Lotus Pharmaceutical and Handa Pharmaceuticals

The main advantage of trading using opposite Lotus Pharmaceutical and Handa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lotus Pharmaceutical position performs unexpectedly, Handa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Handa Pharmaceuticals will offset losses from the drop in Handa Pharmaceuticals' long position.
The idea behind Lotus Pharmaceutical Co and Handa Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals